Your browser doesn't support javascript.
loading
Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
Sorrentino, Vincent G; Thota, Srijan; Gonzalez, Edward A; Rameshwar, Pranela; Chang, Victor T; Etchegaray, Jean-Pierre.
Affiliation
  • Sorrentino VG; Department of Biological Sciences, Rutgers University-Newark, Newark, NJ 07102, USA.
  • Thota S; Department of Biological Sciences, Rutgers University-Newark, Newark, NJ 07102, USA.
  • Gonzalez EA; Department of Biological Sciences, Rutgers University-Newark, Newark, NJ 07102, USA.
  • Rameshwar P; Department of Medicine, Division of Hematology/Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Chang VT; Department of Medicine, Division of Hematology/Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.
  • Etchegaray JP; Veteran Affairs New Jersey Health Care System, East Orange, NJ 07018, USA.
Pharmaceuticals (Basel) ; 14(7)2021 Jul 04.
Article in En | MEDLINE | ID: mdl-34358067

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pharmaceuticals (Basel) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland